Researchers found that NEAT1 overexpression in BC was correlated with poor prognosis of patients and the feedback loop of NEAT1/miR-107/carnitine palmitoyltransferase 1A (CPT1A) 75, NEAT1/miR-124/STAT3 76, NEAT1/miR-448/zinc finger E-box binding homeobox 1 (ZEB1) 77, and NEAT1/miR-101/enhancer of zeste homolog 2 (EZH2) 78, which promotes BC cell proliferation, migration, invasion, and cell cycle progression. Here, EZH2 is linked to breast cancer.